MENU
+Compare
PVLA
Stock ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$40.90
Change
+$1.85 (+4.74%)
Capitalization
452.18M

PVLA Palvella Therapeutics Inc Forecast, Technical & Fundamental Analysis

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies... Show more

PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PVLA with price predictions
Aug 08, 2025

PVLA's Stochastic Oscillator soars into overbought zone

The Stochastic Oscillator for PVLA moved into overbought territory on August 08, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PVLA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PVLA broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PVLA just turned positive on August 08, 2025. Looking at past instances where PVLA's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for PVLA crossed bullishly above the 50-day moving average on July 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PVLA advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where PVLA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PVLA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.137) is normal, around the industry mean (18.662). P/E Ratio (11.983) is within average values for comparable stocks, (54.033). PVLA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PVLA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOGX45.300.17
+0.38%
Thornburg Global Opportunities R6
VSOYX44.620.15
+0.34%
Victory Sycamore Small Company Opp Y
BDAUX32.150.09
+0.28%
Baron Durable Advantage R6
AXMNX15.48N/A
N/A
Acclivity Mid Cap Multi-Style N
MCGAX10.77-0.07
-0.65%
Transamerica Mid Cap Growth A

PVLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with MLEC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+4.74%
MLEC - PVLA
53%
Loosely correlated
N/A
DRMA - PVLA
42%
Loosely correlated
+1.35%
ERAS - PVLA
36%
Loosely correlated
-4.11%
OCUL - PVLA
34%
Loosely correlated
-0.73%
ARCT - PVLA
33%
Poorly correlated
-0.58%
More